ELAN
Elanco Animal Health IncorporatedNYSEHealthcareAs of 2026-04-06
Valuation
View DetailsP/E (TTM)
—
PEG
—
P/B
1.75
P/S
2.43
EV/EBITDA
20.70
DCF Value
$4.68
FCF Yield
2.5%
Div Yield
0.0%
Margins & Returns
Gross Margin
46.4%
Operating Margin
5.3%
Net Margin
-4.9%
ROE
-3.5%
ROA
-4.5%
ROIC
2.1%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q4 2025 | $1.14B | $-276.0M | $-0.55 |
| FY 2025 | $4.71B | $-232.0M | $-0.47 |
| Q3 2025 | $1.14B | $-34.0M | $-0.07 |
| Q2 2025 | $1.24B | $11.0M | $0.02 |
Analyst Ratings
View AllTrading Activity
Insider Trades
View AllCompany Info
Sector
Healthcare
Industry
—
Country
US
Exchange
NYSE
Beta
1.88
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.